These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 23771854)
41. Prediction of micafungin area under the curve data by using peak concentration: applicability and utility in antifungal therapy. Srinivas NR Future Microbiol; 2016; 11(4):485-90. PubMed ID: 27070500 [TBL] [Abstract][Full Text] [Related]
42. Micafungin concentrations from brain tissue and pancreatic pseudocyst fluid. Lat A; Thompson GR; Rinaldi MG; Dorsey SA; Pennick G; Lewis JS Antimicrob Agents Chemother; 2010 Feb; 54(2):943-4. PubMed ID: 19933794 [TBL] [Abstract][Full Text] [Related]
44. Different doses of micafungin for prophylaxis of invasive fungal diseases in hemato-oncological high-risk patients: a web-based non-interventional trial in four large university hospitals in Germany. Heimann SM; Vehreschild MJ; Meintker L; Heinz W; Schroeder T; von Bergwelt-Baildon M; Cornely OA; Vehreschild JJ Transpl Infect Dis; 2014 Dec; 16(6):968-74. PubMed ID: 25371351 [TBL] [Abstract][Full Text] [Related]
45. In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species. Nishi I; Sunada A; Toyokawa M; Asari S; Iwatani Y J Infect Chemother; 2009 Feb; 15(1):1-5. PubMed ID: 19280292 [TBL] [Abstract][Full Text] [Related]
46. Efficacy and safety of micafungin for febrile neutropenia in pediatric patients with hematological malignancies: a multicenter prospective study. Kobayashi R; Suzuki N; Yoshida M; Iizuka S; Suzuki D; Sano H; Kudoh T J Pediatr Hematol Oncol; 2013 Oct; 35(7):e276-9. PubMed ID: 23743960 [TBL] [Abstract][Full Text] [Related]
47. Pharmacokinetic and safety profiles of repeated-dose prophylactic micafungin in children and adolescents undergoing hematopoietic stem cell transplantation. Albano E; Azie N; Roy M; Townsend R; Arrieta A J Pediatr Hematol Oncol; 2015 Jan; 37(1):e45-50. PubMed ID: 25072363 [TBL] [Abstract][Full Text] [Related]
48. Pharmacokinetics of an elevated dosage of micafungin in premature neonates. Smith PB; Walsh TJ; Hope W; Arrieta A; Takada A; Kovanda LL; Kearns GL; Kaufman D; Sawamoto T; Buell DN; Benjamin DK Pediatr Infect Dis J; 2009 May; 28(5):412-5. PubMed ID: 19319022 [TBL] [Abstract][Full Text] [Related]
49. Clinical pharmacodynamic index identification for micafungin in esophageal candidiasis: dosing strategy optimization. Andes DR; Reynolds DK; Van Wart SA; Lepak AJ; Kovanda LL; Bhavnani SM Antimicrob Agents Chemother; 2013 Nov; 57(11):5714-6. PubMed ID: 23959319 [TBL] [Abstract][Full Text] [Related]
50. Differential in vivo activities of anidulafungin, caspofungin, and micafungin against Candida glabrata isolates with and without FKS resistance mutations. Arendrup MC; Perlin DS; Jensen RH; Howard SJ; Goodwin J; Hope W Antimicrob Agents Chemother; 2012 May; 56(5):2435-42. PubMed ID: 22354305 [TBL] [Abstract][Full Text] [Related]
51. Lack of pharmacokinetic drug interaction between oral posaconazole and caspofungin or micafungin. Krishna G; Vickery D; Ma L; Yu X; Noren C; Power E; Beresford E; Medlock M J Clin Pharmacol; 2011 Jan; 51(1):84-92. PubMed ID: 20489029 [TBL] [Abstract][Full Text] [Related]
52. Pharmacokinetics of micafungin in subjects with severe hepatic dysfunction. Undre N; Pretorius B; Stevenson P Eur J Drug Metab Pharmacokinet; 2015 Sep; 40(3):285-93. PubMed ID: 24888485 [TBL] [Abstract][Full Text] [Related]
53. Population pharmacokinetics of micafungin in neonates and young infants. Hope WW; Smith PB; Arrieta A; Buell DN; Roy M; Kaibara A; Walsh TJ; Cohen-Wolkowiez M; Benjamin DK Antimicrob Agents Chemother; 2010 Jun; 54(6):2633-7. PubMed ID: 20308367 [TBL] [Abstract][Full Text] [Related]
54. Pharmacokinetics and Safety of Micafungin in Infants Supported With Extracorporeal Membrane Oxygenation. Autmizguine J; Hornik CP; Benjamin DK; Brouwer KL; Hupp SR; Cohen-Wolkowiez M; Watt KM Pediatr Infect Dis J; 2016 Nov; 35(11):1204-1210. PubMed ID: 27314826 [TBL] [Abstract][Full Text] [Related]
56. Efficacy of Extended-Interval Dosing of Micafungin Evaluated Using a Pharmacokinetic/Pharmacodynamic Study with Humanized Doses in Mice. Lepak A; Marchillo K; VanHecker J; Azie N; Andes D Antimicrob Agents Chemother; 2016 Jan; 60(1):674-7. PubMed ID: 26552968 [TBL] [Abstract][Full Text] [Related]